Advertisement Biolab to open new R&D centre in Greater Toronto Area - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Biolab to open new R&D centre in Greater Toronto Area

Brazilian pharmaceutical firm Biolab Farmacêutica is opening a new research and development (R&D) centre in the Greater Toronto Area in Canada.

The new R&D centre is part of the company’s global expansion plans to invest BRL20m ($5.6m) in equipment, facilities and technical staff.

Initially, 20 specialized professionals will work in the new 1,000m² R&D centre, which will be an extension of the company’s Itapecerica da Serra R&D centre in Brazil, and the two operations will be fully integrated.

Biolab CEO Cleiton de Castro Marques said: "When we started planning our R&D centre abroad, we wanted to set it up in an innovative region with incentives and openness to partnerships and business.

"We found these features in Ontario, which has the ideal conditions for us to move forward in our pursuit of cutting edge innovation."

The company’s decision to open a Canadian R&D Centre has received guidance from the commercial section at Canada’s Consulate General in São Paulo, the Commercial Consul of Ontario in Brazil, the City of Mississauga, and Invest Toronto.

Biolab is a provider of prescription drug sales for cardiology and is ranked fourth in sales for dermatology in Brazil.

The company also plays a major role in gynecology, orthopedics, rheumatology, and pediatrics, and has over 100 products in its portfolio.